2. How do we proceed?

In this section we summarise the most important features of the COVID19-ITS-KISS method:

  • Surveillance component within the ITS-KISS should ideally run concurrent to the ITS-KISS infection surveillance programme
  • Patients included: all COVID-19 patients at the participating ITS
  • Patient-related surveillance method with documentation of data for each COVID-19 ITS patient (also for patients without a surveillance indicative event)
  • Events included in surveillance:
  1. Pathogen change during the time in the intensive care unit (ITS) for respiratory tract infections brought along
  2. New secondary sepsis during the ITS stay with respiratory tract infections brought along
  3. New nosocomial respiratory tract infections during the ITS stay
  4. New primary sepsis during the ITS stay
  5. New MRP findings during the ITS stay

Thanks to the BMBF funding, the study participants receive an expense allowance of 20 euros for each COVID-19 patient included.Data can be entered both retrospectively for the current pandemic and prospectively for the upcoming months.  Please note, however, that a maximum of 150 COVID-19 ITS patients per participating hospital can be paid (depending on the actual number of participants). A positive ethics vote by the ethics committee and a data protection vote were of course received in advance.

Go back